Sandoz Canada Inc.
Sandoz Canada Inc. has met with MPs 5 times since January 2024, reaching 5 MPs across 2 parties. Most recent contact: March 26, 2026.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
"In line with current government priorities, ensure greater harmonisation of policies from the Departments of Innovation, Science and Economic Development and Health Canada's regulatory efficiency and streamlining efforts with regard to drug regulation and approval, particularly under the Food and Drugs Act for pharmaceutical products offered for sale in Canada. The objective is to make quality generic and biosimilar medicines available more quickly in Canada, in the interests of patients and the provinces and territories, while generating substantial savings for private and public plans."
March 26, 2026 · Mélanie Joly · Liberal · Health; Budget; Economic Development
As part of its renewed biomanufacturing strategy, the Federal Governement has announced its intentions to reinvest in this strategic sector. Sandoz Canada is interested in initiating discussions in this contexte with the potential objective of a joint investment in the life sciences sector.
January 17, 2025 · Xavier Barsalou-Duval · Bloc Québécois · Health; Industry; Science and Technology; Economic Development
Health Canada regarding the Cannabis Act (C-45) for medicinal cannabis
November 15, 2024 · Luc Thériault · Bloc Québécois · Health; Industry; Economic Development
Full meeting log
5 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2026-03-26 | Mélanie Joly · Liberal |
| 2026-03-26 | Marjorie Michel · Liberal |
| 2025-01-17 | Xavier Barsalou-Duval · Bloc Québécois |
| 2024-11-15 | Luc Thériault · Bloc Québécois |
| 2024-05-30 | Jean-Denis Garon · Bloc Québécois |